Literature DB >> 21538838

Identification of p.A684V missense mutation in the WFS1 gene as a frequent cause of autosomal dominant optic atrophy and hearing impairment.

Nanna D Rendtorff1, Marianne Lodahl, Houda Boulahbel, Ida R Johansen, Arti Pandya, Katherine O Welch, Virginia W Norris, Kathleen S Arnos, Maria Bitner-Glindzicz, Sarah B Emery, Marilyn B Mets, Toril Fagerheim, Kristina Eriksson, Lars Hansen, Helene Bruhn, Claes Möller, Sture Lindholm, Stefan Ensgaard, Marci M Lesperance, Lisbeth Tranebjaerg.   

Abstract

Optic atrophy (OA) and sensorineural hearing loss (SNHL) are key abnormalities in several syndromes, including the recessively inherited Wolfram syndrome, caused by mutations in WFS1. In contrast, the association of autosomal dominant OA and SNHL without other phenotypic abnormalities is rare, and almost exclusively attributed to mutations in the Optic Atrophy-1 gene (OPA1), most commonly the p.R445H mutation. We present eight probands and their families from the US, Sweden, and UK with OA and SNHL, whom we analyzed for mutations in OPA1 and WFS1. Among these families, we found three heterozygous missense mutations in WFS1 segregating with OA and SNHL: p.A684V (six families), and two novel mutations, p.G780S and p.D797Y, all involving evolutionarily conserved amino acids and absent from 298 control chromosomes. Importantly, none of these families harbored the OPA1 p.R445H mutation. No mitochondrial DNA deletions were detected in muscle from one p.A684V patient analyzed. Finally, wolframin p.A684V mutant ectopically expressed in HEK cells showed reduced protein levels compared to wild-type wolframin, strongly indicating that the mutation is disease-causing. Our data support OA and SNHL as a phenotype caused by dominant mutations in WFS1 in these additional eight families. Importantly, our data provide the first evidence that a single, recurrent mutation in WFS1, p.A684V, may be a common cause of ADOA and SNHL, similar to the role played by the p.R445H mutation in OPA1. Our findings suggest that patients who are heterozygous for WFS1 missense mutations should be carefully clinically examined for OA and other manifestations of Wolfram syndrome.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21538838      PMCID: PMC3100366          DOI: 10.1002/ajmg.a.33970

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  30 in total

1.  Mutations in the Wolfram syndrome 1 gene (WFS1) are a common cause of low frequency sensorineural hearing loss.

Authors:  I N Bespalova; G Van Camp; S J Bom; D J Brown; K Cryns; A T DeWan; A E Erson; K Flothmann; H P Kunst; P Kurnool; T A Sivakumaran; C W Cremers; S M Leal; M Burmeister; M M Lesperance
Journal:  Hum Mol Genet       Date:  2001-10-15       Impact factor: 6.150

2.  Progressive increase of the mutated mitochondrial DNA fraction in Kearns-Sayre syndrome.

Authors:  N G Larsson; E Holme; B Kristiansson; A Oldfors; M Tulinius
Journal:  Pediatr Res       Date:  1990-08       Impact factor: 3.756

3.  Presence of a major WFS1 mutation in Spanish Wolfram syndrome pedigrees.

Authors:  M Gómez-Zaera; T M Strom; B Rodríguez; X Estivill; T Meitinger; V Nunes
Journal:  Mol Genet Metab       Date:  2001-01       Impact factor: 4.797

4.  Non-syndromic progressive hearing loss DFNA38 is caused by heterozygous missense mutation in the Wolfram syndrome gene WFS1.

Authors:  T L Young; E Ives; E Lynch; R Person; S Snook; L MacLaren; T Cater; A Griffin; B Fernandez; M K Lee; M C King; T Cator
Journal:  Hum Mol Genet       Date:  2001-10-15       Impact factor: 6.150

5.  Frequency and distribution of GJB2 (connexin 26) and GJB6 (connexin 30) mutations in a large North American repository of deaf probands.

Authors:  Arti Pandya; Kathleen S Arnos; Xia J Xia; Katherine O Welch; Susan H Blanton; Thomas B Friedman; Guillermina Garcia Sanchez; Xiu Z Liu MD; Robert Morell; Walter E Nance
Journal:  Genet Med       Date:  2003 Jul-Aug       Impact factor: 8.822

6.  Wolfram syndrome: structural and functional analyses of mutant and wild-type wolframin, the WFS1 gene product.

Authors:  Sabine Hofmann; Christine Philbrook; Klaus-Dieter Gerbitz; Matthias F Bauer
Journal:  Hum Mol Genet       Date:  2003-08-15       Impact factor: 6.150

7.  A novel mutation in the OPA1 gene in a Japanese patient with optic atrophy.

Authors:  Satoko Shimizu; Naoki Mori; Mari Kishi; Hirohisa Sugata; Akiko Tsuda; Nobue Kubota
Journal:  Am J Ophthalmol       Date:  2003-02       Impact factor: 5.258

Review 8.  Mutational spectrum of the WFS1 gene in Wolfram syndrome, nonsyndromic hearing impairment, diabetes mellitus, and psychiatric disease.

Authors:  Kim Cryns; Theru A Sivakumaran; Jody M W Van den Ouweland; Ronald J E Pennings; Cor W R J Cremers; Kris Flothmann; Terry-Lynn Young; Richard J H Smith; Marci M Lesperance; Guy Van Camp
Journal:  Hum Mutat       Date:  2003-10       Impact factor: 4.878

9.  The association of autosomal dominant optic atrophy and moderate deafness may be due to the R445H mutation in the OPA1 gene.

Authors:  Patrizia Amati-Bonneau; Sylvie Odent; Christelle Derrien; Laurent Pasquier; Yves Malthiéry; Pascal Reynier; Dominique Bonneau
Journal:  Am J Ophthalmol       Date:  2003-12       Impact factor: 5.258

10.  Autosomal dominant optic neuropathy and sensorineual hearing loss associated with a novel mutation of WFS1.

Authors:  Barend F T Hogewind; Ronald J E Pennings; Frans A Hol; Henricus P M Kunst; Elisabeth H Hoefsloot; Johannes R M Cruysberg; Cor W R J Cremers
Journal:  Mol Vis       Date:  2010-01-12       Impact factor: 2.367

View more
  45 in total

Review 1.  Dominant optic atrophy.

Authors:  Guy Lenaers; Christian Hamel; Cécile Delettre; Patrizia Amati-Bonneau; Vincent Procaccio; Dominique Bonneau; Pascal Reynier; Dan Milea
Journal:  Orphanet J Rare Dis       Date:  2012-07-09       Impact factor: 4.123

Review 2.  Current Landscape of Treatments for Wolfram Syndrome.

Authors:  Damien Abreu; Fumihiko Urano
Journal:  Trends Pharmacol Sci       Date:  2019-08-13       Impact factor: 14.819

3.  Identification of a missense variant in the WFS1 gene that causes a mild form of Wolfram syndrome and is associated with risk for type 2 diabetes in Ashkenazi Jewish individuals.

Authors:  Vikas Bansal; Bernhard O Boehm; Ariel Darvasi
Journal:  Diabetologia       Date:  2018-07-16       Impact factor: 10.122

4.  Genetic Counseling for Diabetes Mellitus.

Authors:  Stephanie A Stein; Kristin L Maloney; Toni I Pollin
Journal:  Curr Genet Med Rep       Date:  2014-06-01

5.  Dominant ER Stress-Inducing WFS1 Mutations Underlie a Genetic Syndrome of Neonatal/Infancy-Onset Diabetes, Congenital Sensorineural Deafness, and Congenital Cataracts.

Authors:  Elisa De Franco; Sarah E Flanagan; Takuya Yagi; Damien Abreu; Jana Mahadevan; Matthew B Johnson; Garan Jones; Fernanda Acosta; Mphele Mulaudzi; Ngee Lek; Vera Oh; Oliver Petz; Richard Caswell; Sian Ellard; Fumihiko Urano; Andrew T Hattersley
Journal:  Diabetes       Date:  2017-05-03       Impact factor: 9.461

Review 6.  Neonatal diabetes: an expanding list of genes allows for improved diagnosis and treatment.

Authors:  Siri Atma W Greeley; Rochelle N Naylor; Louis H Philipson; Graeme I Bell
Journal:  Curr Diab Rep       Date:  2011-12       Impact factor: 4.810

7.  Wolfram gene (WFS1) mutation causes autosomal dominant congenital nuclear cataract in humans.

Authors:  Vanita Berry; Cheryl Gregory-Evans; Warren Emmett; Naushin Waseem; Jacob Raby; DeQuincy Prescott; Anthony T Moore; Shomi S Bhattacharya
Journal:  Eur J Hum Genet       Date:  2013-03-27       Impact factor: 4.246

8.  Significant expressivity of Wolfram syndrome: phenotypic assessment of two known and one novel mutation in the WFS1 gene in three Iranian families.

Authors:  Maryam Sobhani; Mohammad Amin Tabatabaiefar; Asadollah Rajab; Abdol-Mohammad Kajbafzadeh; Mohammad Reza Noori-Daloii
Journal:  Mol Biol Rep       Date:  2014-08-31       Impact factor: 2.316

9.  Clinical utility gene card for: Wolfram syndrome.

Authors:  Mariya Moosajee; Patrick Yu-Wai-Man; Cécile Rouzier; Maria Bitner-Glindzicz; Richard Bowman
Journal:  Eur J Hum Genet       Date:  2016-05-25       Impact factor: 4.246

10.  Monogenic and syndromic diabetes due to endoplasmic reticulum stress.

Authors:  Stephen I Stone; Damien Abreu; Janet B McGill; Fumihiko Urano
Journal:  J Diabetes Complications       Date:  2020-05-08       Impact factor: 2.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.